131 related articles for article (PubMed ID: 3393746)
1. [General and local hormonal therapy in scleroderma].
Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
[No Abstract] [Full Text] [Related]
2. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
3. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
Didenko IG
Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
[No Abstract] [Full Text] [Related]
4. [Effect of piascledine treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
[No Abstract] [Full Text] [Related]
5. Stimulating circulation to end stasis in scleroderma.
Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
[No Abstract] [Full Text] [Related]
6. [The course of scleroderma following treatment with carnitin].
Nitzschner H
Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
[No Abstract] [Full Text] [Related]
7. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
[No Abstract] [Full Text] [Related]
8. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
Dovzhanskiĭ SI; Slesarenko NA
Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
[No Abstract] [Full Text] [Related]
9. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
10. Salazopyrin (azulfidine) treatment in scleroderma.
Dover N
Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
[No Abstract] [Full Text] [Related]
11. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
Baum S; Pavlotsky F; Shpiro D; Trau H
Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
[No Abstract] [Full Text] [Related]
12. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Nitzschner H
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
[No Abstract] [Full Text] [Related]
13. [Trafuril reaction in scleroderma].
Urban J
Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
[No Abstract] [Full Text] [Related]
14. [Use of Tebessal in scleroderma].
Mattos O; de Oliveira Neto MP
Rev Bras Med; 1972 Mar; 29(3):139-40. PubMed ID: 5033154
[No Abstract] [Full Text] [Related]
15. [Therapeutic effectiveness of treatment of patients with scleroderma at the Pyatigorsk Spa].
Braĭtsev AV; Kessel' VP; Marzeeva GI; Shliapak EA; Angelova VS
Vestn Dermatol Venerol; 1971 Oct; 45(10):35-9. PubMed ID: 5134075
[No Abstract] [Full Text] [Related]
16. [Scleroderma and esophageal changes: treatment and instrumental control].
Altomare GF; Allara A; Pigatto PD
G Ital Dermatol Venereol; 1984; 119(4):263-6. PubMed ID: 6490099
[No Abstract] [Full Text] [Related]
17. [Characteristics of the course of scleroderma in diabetes mellitus].
Khamaganova IV
Sov Med; 1990; (2):72-6. PubMed ID: 2356535
[No Abstract] [Full Text] [Related]
18. [Dynamics of hydroxyproline content as the indicator of the severity of the course and the effectiveness of treatment of focal scleroderma].
Fedorova EG; Lashmanova AP
Vestn Dermatol Venerol; 1978 Dec; (12):18-22. PubMed ID: 570330
[No Abstract] [Full Text] [Related]
19. Scleroderma--developing measures of response.
Furst DE; Khanna D; Mattucci-Cerinic M; Silman AJ; Merkel PA; Foeldvari I;
J Rheumatol; 2005 Dec; 32(12):2477-80. PubMed ID: 16331791
[TBL] [Abstract][Full Text] [Related]
20. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
